Literature DB >> 23430897

Identification of 11 Novel Homogentisate 1,2 Dioxygenase Variants in Alkaptonuria Patients and Establishment of a Novel LOVD-Based HGD Mutation Database.

Andrea Zatkova1, Tatiana Sedlackova, Jan Radvansky, Helena Polakova, Martina Nemethova, Robert Aquaron, Ismail Dursun, Jeannette L Usher, Ludevit Kadasi.   

Abstract

Enzymatic loss in alkaptonuria (AKU), an autosomal recessive disorder, is caused by mutations in the homogentisate 1,2 dioxygenase (HGD) gene, which decrease or completely inactivate the function of the HGD protein to metabolize homogentisic acid (HGA). AKU shows a very low prevalence (1:100,000-250,000) in most ethnic groups, but there are countries with much higher incidence, such as Slovakia and the Dominican Republic. In this work, we report 11 novel HGD mutations identified during analysis of 36 AKU patients and 41 family members from 27 families originating from 9 different countries, mainly from Slovakia and France. In Slovak patients, we identified two additional mutations, thus a total number of HGD mutations identified in this small country is 12. In order to record AKU-causing mutations and variants of the HGD gene, we have created a HGD mutation database that is open for future submissions and is available online ( http://hgddatabase.cvtisr.sk/ ). It is founded on the Leiden Open (source) Variation Database (LOVD) system and includes data from the original AKU database ( http://www.alkaptonuria.cib.csic.es ) and also all so far reported variants and AKU patients. Where available, HGD-haplotypes associated with the mutations are also presented. Currently, this database contains 148 unique variants, of which 115 are reported pathogenic mutations. It provides a valuable tool for information exchange in AKU research and care fields and certainly presents a useful data source for genotype-phenotype correlations and also for future clinical trials.

Entities:  

Year:  2011        PMID: 23430897      PMCID: PMC3509877          DOI: 10.1007/8904_2011_68

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  29 in total

1.  Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  An update on molecular genetics of Alkaptonuria (AKU).

Authors:  Andrea Zatkova
Journal:  J Inherit Metab Dis       Date:  2011-07-01       Impact factor: 4.982

3.  The molecular basis of alkaptonuria.

Authors:  J M Fernández-Cañón; B Granadino; D Beltrán-Valero de Bernabé; M Renedo; E Fernández-Ruiz; M A Peñalva; S Rodríguez de Córdoba
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

4.  Molecular defects in alkaptonuria.

Authors:  A Gehrig; S R Schmidt; C R Müller; S Srsen; K Srsnova; W Kress
Journal:  Cytogenet Cell Genet       Date:  1997

5.  The human homogentisate 1,2-dioxygenase (HGO) gene.

Authors:  B Granadino; D Beltrán-Valero de Bernabé; J M Fernández-Cañón; M A Peñalva; S Rodríguez de Córdoba
Journal:  Genomics       Date:  1997-07-15       Impact factor: 5.736

6.  Allelic heterogeneity of alkaptonuria in Central Europe.

Authors:  C R Müller; A Fregin; S Srsen; K Srsnova; B Halliger-Keller; U Felbor; E Seemanova; W Kress
Journal:  Eur J Hum Genet       Date:  1999-09       Impact factor: 4.246

7.  Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.

Authors:  D Beltrán-Valero de Bernabé; B Granadino; I Chiarelli; B Porfirio; E Mayatepek; R Aquaron; M M Moore; J J Festen; R Sanmartí; M A Peñalva; S R de Córdoba
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

8.  Analysis of alkaptonuria (AKU) mutations and polymorphisms reveals that the CCC sequence motif is a mutational hot spot in the homogentisate 1,2 dioxygenase gene (HGO).

Authors:  D Beltrán-Valero de Bernabé; F J Jimenez; R Aquaron; S Rodríguez de Córdoba
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

9.  Molecular analyses of the HGO gene mutations in Turkish alkaptonuria patients suggest that the R58fs mutation originated from central Asia and was spread throughout Europe and Anatolia by human migrations.

Authors:  O Uyguner; E Goicoechea de Jorge; A Cefle; T Baykal; H Kayserili; K Cefle; M Demirkol; M Yuksel-Apak; S Rodriguez de Córdoba; B Wollnik
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

10.  Homozygosity mapping of the gene for alkaptonuria to chromosome 3q2.

Authors:  M R Pollak; Y H Chou; J J Cerda; B Steinmann; B N La Du; J G Seidman; C E Seidman
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

View more
  11 in total

1.  An update on molecular genetics of Alkaptonuria (AKU).

Authors:  Andrea Zatkova
Journal:  J Inherit Metab Dis       Date:  2011-07-01       Impact factor: 4.982

2.  Analysis of HGD Gene Mutations in Patients with Alkaptonuria from the United Kingdom: Identification of Novel Mutations.

Authors:  Jeannette L Usher; David B Ascher; Douglas E V Pires; Anna M Milan; Tom L Blundell; Lakshminarayan R Ranganath
Journal:  JIMD Rep       Date:  2015-02-15

3.  A Founder Effect for the HGD G360R Mutation in Italy: Implications for a Regional Screening of Alkaptonuria.

Authors:  Berardino Porfirio; Roberta Sestini; Greta Gorelli; Miriam Cordovana; Alessandro Mannoni; Jeanette L Usher; Wendy J Introne; William A Gahl; Thierry Vilboux
Journal:  JIMD Rep       Date:  2016-03-10

4.  Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy.

Authors:  Martina Nemethova; Jan Radvanszky; Ludevit Kadasi; David B Ascher; Douglas E V Pires; Tom L Blundell; Berardino Porfirio; Alessandro Mannoni; Annalisa Santucci; Lia Milucci; Silvia Sestini; Gianfranco Biolcati; Fiammetta Sorge; Caterina Aurizi; Robert Aquaron; Mohammed Alsbou; Charles Marques Lourenço; Kanakasabapathi Ramadevi; Lakshminarayan R Ranganath; James A Gallagher; Christa van Kan; Anthony K Hall; Birgitta Olsson; Nicolas Sireau; Hana Ayoob; Oliver G Timmis; Kim-Hanh Le Quan Sang; Federica Genovese; Richard Imrich; Jozef Rovensky; Rangan Srinivasaraghavan; Shruthi K Bharadwaj; Ronen Spiegel; Andrea Zatkova
Journal:  Eur J Hum Genet       Date:  2015-03-25       Impact factor: 4.246

5.  Alkaptonuria: A case report.

Authors:  Nirupama Damarla; Prathima Linga; Mallika Goyal; Sanjay Reddy Tadisina; G Satyanarayana Reddy; Hymavathi Bommisetti
Journal:  Indian J Ophthalmol       Date:  2017-06       Impact factor: 1.848

6.  ApreciseKUre: an approach of Precision Medicine in a Rare Disease.

Authors:  Ottavia Spiga; Vittoria Cicaloni; Andrea Bernini; Andrea Zatkova; Annalisa Santucci
Journal:  BMC Med Inform Decis Mak       Date:  2017-04-14       Impact factor: 2.796

7.  Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.

Authors:  Juliette H Hughes; Ke Liu; Antonius Plagge; Peter J M Wilson; Hazel Sutherland; Brendan P Norman; Andrew T Hughes; Craig M Keenan; Anna M Milan; Takao Sakai; Lakshminarayan R Ranganath; James A Gallagher; George Bou-Gharios
Journal:  Hum Mol Genet       Date:  2019-12-01       Impact factor: 6.150

Review 8.  Alkaptonuria: Current Perspectives.

Authors:  Andrea Zatkova; Lakshminarayan Ranganath; Ludevit Kadasi
Journal:  Appl Clin Genet       Date:  2020-01-23

9.  A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.

Authors:  Andrea Bernini; Elena Petricci; Andrea Atrei; Maria Camilla Baratto; Fabrizio Manetti; Annalisa Santucci
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

10.  Variant Analysis of Alkaptonuria Families with Significant Founder Effect in Jordan.

Authors:  Raida Khalil; Dema Ali; Nesrin Mwafi; Arwa Alsaraireh; Loiy Obeidat; Eman Albsoul; Ibrahim Al Sbou'
Journal:  Biomed Res Int       Date:  2021-03-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.